Ex vivo generation of dendritic cells from CD34+ cells in gas-permeable containers under serum-free conditions

Journal of Hematotherapy and Stem Cell Research

Volumn 7, Issue 5, 1998, Pages 403-411

  Kowalkowski, Kenneth L ^a   Alzona, Mortimer T ^a   Aono, Frederick M ^a   Van Epps, Dennis E ^a   Vachula, Mona ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY PRODUCING CELL; ARTICLE; CELL CULTURE; CELL SEPARATION; CELL STRUCTURE; CULTURE MEDIUM; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LABORATORY; PRIORITY JOURNAL;

ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CULTURE MEDIA, SERUM-FREE; DENDRITIC CELLS; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 0031795172     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1998.7.403     Document Type: Article

References (47)

1. Steinman, R.M. Dendritic cells and immune-based therapies. Exp. Hematol. 24:859, 1996.
2. Engleman, E.G. Dendritic cells in the treatment of cancer. Biol. Blood Marrow Transplant. 2:115, 1996.
3. Bhardwaj, N., Young, J.W., Nisanian, A.J., et al. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses. J. Exp. Med. 178:633, 1993.
4. Steinman, R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271, 1991.
5. Caux, C., Saeland, S., Favre, C., et al. Tumor necrosis factor-alpha strongly potentiates interleukin-3 and granulocyte-macrophage colony-stimulating factor-induced proliferation of human CD34+ hematopoietic progenitor cells. Blood 75:2292, 1990.
6. Caux, C., Durand, I., Moreau, I., et al. Tumor necrosis factor-alpha cooperates with interleukin-3 in the recruitment of a primitive subset of human CD34+ progenitors. J. Exp. Med. 177:1815, 1993.
7. Caux, C., Massacrier, C., Dezutter-Dambuyant, C., et al. Human dendritic Langerhans cells generated in vitro from CD34+ progenitors can prime naive CD4+ T cells and process soluble antigen. J. Immunol. 155:5427, 1995.
8. Caux, C., Vanbervliet, B., Massacrier, C., et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+ TNFα. J. Exp. Med. 184:695, 1996.
9. Santiago-Schwarz, F., Belilos, E., Diamond, B., et al. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J. Leukocyte Biol. 52:274, 1992.
10. Santiago-Schwarz, F., Divaris, N., Kay, C., et al. Mechanisms of tumor necrosis factor- granulocyte-macrophage colony-stimulating factor-induced dendritic cell development. Blood 82:3019, 1993.
11. Reid, C.D.L., Stackpoole, A., Meager, A., et al. Interaction of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J. Immunol. 149:2681, 1992.
12. Young, J.W., Szabolcs, P., & Moore, M.A.S. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor α. J. Exp. Med. 182:1111, 1995.
13. Szabolcs, P., Moore, M.A.S., & Young, J.W. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte/macrophage colony-stimulating, and TNFα. J. Immunol. 154:5851, 1995.
14. Strunk, D., Rappersberger, K., Egger, C., et al. Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. Blood 87:1292, 1996.
15. Siena, S., DiNicola, M., Bregni, M., et al. Massive ex vivo generation of functional dendritic cells from mobilized CD34 blood progenitors for anticancer therapy. Exp. Hematol. 23:1463, 1995.
16. Piemont, L., Bernasconi, S., Luini, W., et al. IL-13 support differentiation of dendritic cells from circulating precursors in concert with GM-CSF. Eur. Cytokine Network 6:245, 1995.
17. Bernhard, H., Disis, M.L., Heimfeld, S., et al. Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res. 55:1099, 1995.
18. Rosenzwajg, M., Canque, B., & Gluckman, J.C. Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells. Blood 87:535, 1996.
19. Ye, Z., Gee, A.P., Bowers, W.E., et al. In vitro expansion and characterization of dendritic cells from human bone marrow CD34+ cells. Bone Marrow Transplant. 18:997, 1996.
20. Caux, C., Vanbervliet, B., Massacrier, C., et al. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180:1841, 1994.
21. Yokozeki, H., Katayama, I., Ohki, O., et al. Functional CD86 on cultured human Langerhans cells. J. Invest. Dermatol. 106:147, 1996.
22. Nakajima, T., Watanabe, S., Sato, Y., et al. An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues. Am. J. Surg. Pathol. 6:715, 1982.
23. Takahashi, K., Yamaguchi, H., Ishizeki, J., et al. Immunohistochemical and immunoelectron microscopic localization of S-100 protein in the interdigitating reticulum cell of the human lymph node. Cell Pathol. 37:125, 1981.
24. Crow, M.K. & Kunkel, H.G. Human dendritic cells: Major stimulators of the autologous and allogeneic mixed leukocyte reactions. Clin. Exp. Immunol. 49:338, 1982.
25. Bhardwaj, N., Friedman, S.M., Cole, B.C., et al. Dendritic cells are potent antigen-presenting cells for microbial superantigens. J. Exp. Med. 175:267, 1992.
26. Kanof, M.E. Isolation of T cells using rosetting procedures. In Current Protocols in Immunology, ed. Coligan, J.E. John Wiley and Sons Inc., New York, 1995, 2:7.2.1.
27. Zeid, N.A. & Muller, H.K. S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology 25:338, 1993.
28. Imai, Y. & Yamakawa, M. Dendritic cells in esophageal cancer and lymph node tissues. In Vivo 7:239, 1993.
29. Nakano, T., Oka, K., Takahashi, T., et al. Roles of Langerhans cells and T lymphocytes infiltrating cancer tissues in patients treated by radiation therapy for cervical cancer. Cancer 70:2839, 1992.
30. Oka, K., Nakano, T. & Arai, T. Adenocarcinoma of the cervix treated with radiation alone: Prognostic significance of S-100 protein and vimentin immunostaining. Obstet. Gynecol. 79:347, 1992.
31. Papadimitrou, C.S., Datseris, G., Costopoulos, J.S., et al. Langerhans cells and lymphocyte subsets in human gastrointestinal carcinoma: An immunohistochemical study on frozen sections. Pathol. Pract. 188:989, 1992.
32. Schroder, S., Schwarg, W., Rehpenning, W., et al. Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Am. J. Clin. Pathol. 89:295, 1988.
33. Porgador, A., & Gilboa, E. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182:255, 1995.
34. Mayordomo, J.I., Zorina, T., Storkus, W.J., et al. Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nature Med. 1:1297, 1995.
35. Celluzzi, C.M., Mayordomo, J.I., Storkus, W.J., et al. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183:283, 1996.
36. Bhardwaj, N., Bender, A., Gonzalez, N., et al. Influenza virus-infected dendritic cells stimulate strong proliferate and cytolytic responses from human CD8+ T cells. J. Clin. Invest. 94:797, 1994.
37. Bender, A., Bhardwaj, N., Bui, L.K., et al. Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J. Exp. Med. 182:1663, 1995.
38. Alijagic, S., Moeller, P., Artuc, M., et al. Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur. J. Immunol. 25:3100, 1995.
39. Bakker, A.B.H., Marland, G., de Boer, A.J., et al. Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res. 55:5330, 1995.
40. Tjoa, B., Erickson, S., Barren, R., et al. In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy. Prostate 27:63, 1995.
41. Tjoa, B., Boynton, A., Kenny, G., et al. Presentation of prostate tumor antigens by dendritic cells stimulates T cell proliferation and cytotoxicity. Prostate 28:65, 1996.
42. Radmayr, C., Boeck, G., Hobisch, A., et al. Dendritic antigen-presenting cells from the peripheral blood of renal-cell carcinoma patients. Int. J. Cancer 63:627, 1995.
43. Hsu, F.J., Benike, C., Fagnoni, F., et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Med. 2:52, 1996.
44. Lasmezas, C.I., Deslys, J.P., Robain, O., et al. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275:402, 1997.
45. Selvaggi, T.A., Walker, R.E., & Fleisher, T.A. Development of antibodies to fetal calf serum with Arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89:776, 1997.
46. Williams, S.W., Lee, W.J., Bender, J.G., et al. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood 87:1687, 1996.
47. Zimmerman, T.M., Bender, J.G., Lee, W.J., et al. Large-scale selection of CD34+ peripheral blood progenitors and expansion of neutrophil precursors for clinical applications. J. Hematother. 5:247, 1996.